Reyataz
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Un dels principals motius que ens va impulsar en l’eleccio del tema es que es tracta d’untema que pot despertar curiositat entre…
AVos Life sciences has analysed the revenue contribution of organically developed, licensed or co-developed, acquired and joint…
The combination has been found to reduce blood levels of the antiretroviral to about a quarter of what they should be.
Atazanavir (Reyataz) is a protease inhibitor that received FDA approval in June 2003. Other approved drugs in this class include…
Reyataz, protease inhibitor, is to be used in combination with other antiretroviral agents for the treatment of patients with HIV…